Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients.

Clarkson R CraneErin PhebusElizabeth Ingulli

Published in: Pediatric nephrology (Berlin, Germany) (2022)

Our results demonstrate that additional SARS-CoV-2 vaccine doses are not only safe and efficacious in pediatric and adolescent KTR, but may be necessary to optimize antibody response. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keyphrases

sars cov
young adults
mental health
respiratory syndrome coronavirus
childhood cancer
healthcare
psychometric properties